Bangalore’s Cytecare Hospital’s Cancon 2024, its sixth annual cancer conference, brought together oncologists, surgeons and researchers from across the world. The theme of the December 2024 conference was "Oral Cavity Cancer Management Revisited,” noted a write-up sent to Parsiana.
"The meet delved into the latest advancements in the diagnosis, treatment and management of oral cavity cancers, with a special focus on early detection techniques, surgical interventions and patient reported outcomes…
From (l): Drs Krishnappa, Ferzaan Engineer, Carsten Palme
and cancer survivor Hayath Shariff at Cancon 2024
"Oral cavity cancer is the most common cancer in India, particularly among those who use tobacco or consume alcohol.
"According to the World Health Organization (WHO), India accounts for almost a third of the global incidence and mortality related to oral cancer. Early detection is key to improving survival rates. However, despite the known risks, awareness about oral cancer and regular screenings remains low among the general population…
"According to the Indian Council of Medical Research (ICMR), approximately 1.2 lakh new cases of oral cancer are diagnosed annually in India, with a notable increase in younger populations due to rising tobacco and alcohol consumption. Early detection remains a crucial factor in improving survival rates, and Cancon 2024 helps equip healthcare providers with the latest techniques in screening and diagnosis to address this growing epidemic.”
Dr Kudpaje, senior consultant and Director of Head and Neck Oncology, Cytecare Hospitals added, "Oral cancer remains one of the most treatable cancers when diagnosed early. At Cancon, we aimed to not only provide medical professionals with the latest information but also to empower the public to take proactive steps in managing their oral health. Awareness and early detection are key to saving lives.”
Cytecare Hospitals launched its flagship center, a 150-bed hospital, in November 2016 at Yelahanka, Bangalore.
The co-founder and chairman of Cytecare Hospitals Private Limited is Dr Ferzaan Engineer who has served on the Advisory Board of the Indian Society for Clinical Research (ISCR) and been a member of the Confederation of Indian Indusry — National Committee on Drugs and Pharmaceuticals and the Federation of Indian Chambers of Commerce and Industry — Pharmaceuticals and Biotechnology Committee.
The Hospital conducts global clinical research studies, ensuring continuous learning and improvements for the benefit of patients who come from more than 40 countries, as per the write-up. S. V.